« Starving Cancer Brings Home Bacon for Agios Pharma | Main | When are The Price's Right for Dendreon's Provenge? »

04/16/2010

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b0133ecbd928e970b

Listed below are links to weblogs that reference More Oncology News as Teva Licenses from Mersana:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

Bruce Lehr

Mersana reports results from clinical trial on XMT-1001
http://www.medicalnewstoday.com/articles/186116.php

Bruce Lehr

Read here for more in depth information on Mersana's Fleximer technology and it's benefits from Xconomy.
http://www.xconomy.com/boston/2010/04/13/mersana-strikes-deal-with-teva-worth-up-to-334m-for-long-lasting-cancer-drug/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

April 2014

Sun Mon Tue Wed Thu Fri Sat
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada